• ქართული
  • English
  • AbbVie to buy Botox-maker Allergan in $63 billion deal

    Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.

    Market Quotes by TradingView